Effective treatment of small murine hepatocellular carcinoma by dendritic cells
Wei‐Chen Lee, Hui‐Chuan Wang, Long‐Bin Jeng, Yang‐Jen Chiang, Chen‐Rong Lia, Pei‐Fang Huang, Miin‐Fu Chen, Shiguang Qian, Lina Lu – 30 December 2003 – Hepatocellular carcinoma (HCC) is a common malignancy with a poor prognosis. This investigation examined whether dendritic cell–based immunotherapy can treat murine HCC effectively. Bone marrow–derived dendritic cells were propagated from C57BL/10J mice in GM‐CSF (4 ng/mL) and interleukin (IL)‐4 (1,000 μ/mL). The dendritic cells were pulsed with a Hepa1‐6 lysate overnight and employed to treat murine HCC.